Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2004
Ethnic differences and determinants of diabetes and central obesity among South Asians of PakistanT H Jafar, A S Levey, F M White, et al.
European Review for Medical and Pharmacological Sciences|September 5, 2023
Independent risk factors for COVID-19-associated coagulopathyY B Tor, M Ozbalak, S Kalayoglu-Besisik, et al.
The British Journal of Dermatology|November 17, 2006
Ectodermal dysplasia of hair and nail type: mapping of a novel locus to chromosome 17p12-q21.2M Naeem, M Jelani, K Lee, et al.
The British Journal of Dermatology|July 26, 2016
Invasive melanoma in vivo can be distinguished from basal cell carcinoma, benign naevi and healthy skin by canine olfaction: a proof-of-principle study of differential volatile organic compound emissionC M Willis, L E Britton, M A Swindells, et al.
Tissue Antigens|August 15, 2008
Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's diseaseY Takemoto, T Naruse, K Namba, et al.
Annals of the Rheumatic Diseases|August 31, 2015
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritisK L Winthrop, S-H Park, A Gul, et al.
Annals of the Rheumatic Diseases|April 19, 2008
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Annals of the Rheumatic Diseases|February 5, 2008
EULAR recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|March 30, 2022
Ethnomedicinal uses of plants for various diseases in the remote areas of Changa Manga Forest, PakistanA Sharif, N A Shah, A Rauf, et al.
Annals of the Rheumatic Diseases|August 24, 2011
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypesJasmin B Kuemmerle-Deschner, E Hachulla, R Cartwright, et al.
Pageof 8